Neurogene
(NASDAQ) NGNE
Neurogene Financials at a Glance
Market Cap
$323.32M
Revenue (TTM)
$0.00
Net Income (TTM)
$90.35M
EPS (TTM)
$-4.71
P/E Ratio
-4.41
Dividend
$0.00
Beta (Volatility)
1.43 (Average)
Dividend
$0.00
Beta (Volatility)
1.43 (Average)
Price
$24.00
Volume
370,104.467
Open
$20.94
Price
$24.00
Volume
370,104.467
Open
$20.94
Previous Close
$24.00
Daily Range
$20.94 - $24.85
52-Week Range
$10.46 - $37.27
Dividend
$0.00
Beta (Volatility)
1.43 (Average)
Price
$24.00
Volume
370,104.467
Open
$20.94
Previous Close
$24.00
Daily Range
$20.94 - $24.85
52-Week Range
$10.46 - $37.27
NGNE News
NGNE: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Neurogene
Industry
Biotechnology
Sector
Health CareEmployees
131
CEO
Rachel L. McMinn, PhD
Website
www.neurogene.comHeadquarters
New York City, NY 10011, US
NGNE Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-31%
Return on Capital
-38%
Return on Assets
-31%
Earnings Yield
-22.68%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$323.32M
Shares Outstanding
15.57M
Volume
370.10K
Short Interest
0.00%
Avg. Volume
158.37K
Financials (TTM)
Gross Profit
$3.19M
Operating Income
$103.21M
EBITDA
$103.33M
Operating Cash Flow
$77.17M
Capital Expenditure
$1.18M
Free Cash Flow
$78.36M
Cash & ST Invst.
$269.01M
Total Debt
$9.89M
Neurogene Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$787.00K
+94.9%
Gross Margin
0.00%
N/A
Market Cap
$323.32M
N/A
Market Cap/Employee
$3.02M
N/A
Employees
107
N/A
Net Income
$24.73M
-26.8%
EBITDA
$26.74M
-29.1%
Quarterly Fundamentals
Net Cash
$259.12M
-13.6%
Accounts Receivable
$460.00K
-29.0%
Inventory
$0.00
N/A
Long Term Debt
$6.83M
-27.6%
Short Term Debt
$3.06M
+2.2%
Return on Assets
-31.24%
N/A
Return on Invested Capital
-37.88%
N/A
Free Cash Flow
$16.79M
+4.7%
Operating Cash Flow
$16.67M
+4.7%